Parvovirus Antenatal InfectionSymptoms, Doctors, Treatments, Advances & More
Parvovirus Antenatal Infection Overview
Learn About Parvovirus Antenatal Infection
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Jean Rommelaere practices practicing medicine in Heidelberg, Germany. Ms. Rommelaere is rated as an Elite expert by MediFind in the treatment of Parvovirus Antenatal Infection. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Parvovirus Antenatal Infection, Glioma, Gliomatosis Cerebri, and Cutaneous T-Cell Lymphoma (CTCL).
Modra Murovska practices practicing medicine in Riga, Latvia. Murovska is rated as an Elite expert by MediFind in the treatment of Parvovirus Antenatal Infection. They are also highly rated in 6 other conditions, according to our data. Their clinical expertise encompasses Parvovirus Antenatal Infection, Fetal Parvovirus Syndrome, Fifth Disease, Kidney Transplant, and Bone Marrow Transplant.
Heinz-peter Schultheiss practices practicing medicine in Berlin, Germany. Schultheiss is rated as an Elite expert by MediFind in the treatment of Parvovirus Antenatal Infection. They are also highly rated in 9 other conditions, according to our data. Their clinical expertise encompasses Fetal Parvovirus Syndrome, Myocarditis, Parvovirus Antenatal Infection, Cardiomyopathy, and Heart Transplant.
Summary: RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics. This knowledge gap hinders the design of effective prevention and control strategies. RACSMEI will improve understanding across multiple pathogens using a multidisciplinary One Health...
Summary: The goal of this observational study is to define the rate of intrauterine parvovirus B19 infection and fetal/newborn complications after parvovirus B19 infection of pregnant women. Secondary objectives are risk factors, pregnancy outcomes, long-term sequelae and efficacy of the management interventions.